Finanzwire Finanzwire
Basculer en Français
10832 Companies
235110 Keywords
164013 Articles
125896 Press releases
Headlines Articles Press releases Next Gen Diagnostics Remove
  1. Home
  2. Companies
  3. Next Gen Diagnostics
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/22/2024 at 00:35, 2 years 2 months ago

    Next Gen Diagnostics and Vanderbilt Utilize Whole Genome Sequencing to Detect NICU Infections

    Next Gen Diagnostics Whole Genome Sequencing Neonatal Intensive Care Unit Infection Control Vanderbilt University Medical Center
  • PRESS RELEASE

    published on 05/22/2024 at 00:30, 2 years 2 months ago

    Next Gen Diagnostics and Vanderbilt Report the Use of Whole Genome Sequencing to Detect Transmission of Infection in a Neonatal Intensive Care Unit

    Next Gen Diagnostics and Vanderbilt University Medical Center study reveals the benefits of whole genome sequencing in detecting transmission of bacterial pathogens in NICU infants. Results will be presented at the ASM Conference
    Next Gen Diagnostics Whole Genome Sequencing Vanderbilt University Medical Center Transmission Detection ASM Conference
    Logo of Next Gen Diagnostics
Previous page
1 2
Accesswire
  • Published on 08/13/2026 at 22:38, 1 hour 41 minutes ago

    Predictiv AI Announces Debt Settlement and Provides Additional Details of Previously Announced Consulting Agreement With Aktien Media Inc.

  • Published on 08/13/2026 at 19:55, 4 hours 24 minutes ago

    NuRAN Wireless Receives Nasdaq Approval to List on The Nasdaq Capital Market; Trading Expected to Commence August 17, 2026 and C$7.6 Million Financing to Close August 14, 2026

  • Published on 08/13/2026 at 17:55, 6 hours 24 minutes ago

    Alset AI Announces Agreement to Sell 9.9% Interest in Lyken AI Computing to FingerMotion

  • Published on 08/13/2026 at 14:31, 9 hours 48 minutes ago

    Wi2Wi Announces Strategic Equipment Investments to Expand Production Capacity

  • Published on 08/13/2026 at 14:15, 10 hours 4 minutes ago

    Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th

View all ACCESSWIRE
EQS Group
  • Published on 08/13/2026 at 23:20, 58 minutes ago

    DeFi Technologies Inc. Announces Second Quarter 2026 Financial Results with Revenue of $7.8 Million, Operating Loss of $2.3 Million, and Maintained Strong Balance Sheet

  • Published on 08/13/2026 at 22:56, 1 hour 23 minutes ago

    BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING AND CONCURRENT SHARE REPURCHASE

  • Published on 08/13/2026 at 18:17, 6 hours 1 minute ago

    EQS-Adhoc: Energiekontor AG: Energiekontor adjusts earnings guidance for the 2026 financial year

  • Published on 08/13/2026 at 18:00, 6 hours 18 minutes ago

    Issue of Equity

  • Published on 08/13/2026 at 18:00, 6 hours 19 minutes ago

    Deutsche EuroShop reports good operational performance in the first half of 2026 and confirms its forecast

View all EQS
Les Echos
  • Published on 08/10/2026 at 18:00, 3 days 6 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 17:45, 3 days 6 hours ago

    Weekly share buyback

  • Published on 08/10/2026 at 11:53, 3 days 12 hours ago

    GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

  • Published on 08/10/2026 at 11:36, 3 days 12 hours ago

    GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026

  • Published on 08/10/2026 at 09:22, 3 days 14 hours ago

    Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy